2028 related articles for article (PubMed ID: 28985214)
1. Cancer stem cells revisited.
Batlle E; Clevers H
Nat Med; 2017 Oct; 23(10):1124-1134. PubMed ID: 28985214
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
Najafi M; Mortezaee K; Ahadi R
Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
5. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
Paul R; Dorsey JF; Fan Y
Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.
Najafi M; Farhood B; Mortezaee K; Kharazinejad E; Majidpoor J; Ahadi R
J Cancer Res Clin Oncol; 2020 Jan; 146(1):19-31. PubMed ID: 31734836
[TBL] [Abstract][Full Text] [Related]
7. Plasticity of male germline stem cells and their applications in reproductive and regenerative medicine.
Chen Z; Li Z; He Z
Asian J Androl; 2015; 17(3):367-72. PubMed ID: 25532577
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.
Heng WS; Gosens R; Kruyt FAE
Biochem Pharmacol; 2019 Feb; 160():121-133. PubMed ID: 30557553
[TBL] [Abstract][Full Text] [Related]
9. Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity.
Bernardo MM; Kaplun A; Dzinic SH; Li X; Irish J; Mujagic A; Jakupovic B; Back JB; Van Buren E; Han X; Dean I; Chen YQ; Heath E; Sakr W; Sheng S
Cancer Res; 2015 Sep; 75(18):3970-9. PubMed ID: 26208903
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer defeating? Challenge accepted!
Di Franco S; Todaro M; Dieli F; Stassi G
Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells--the current status of an old concept: literature review and clinical approaches.
Fulawka L; Donizy P; Halon A
Biol Res; 2014 Dec; 47(1):66. PubMed ID: 25723910
[TBL] [Abstract][Full Text] [Related]
12. Defining Adult Stem Cell Function at Its Simplest: The Ability to Replace Lost Cells through Mitosis.
Post Y; Clevers H
Cell Stem Cell; 2019 Aug; 25(2):174-183. PubMed ID: 31374197
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of liver cancer stem cells and clinical correlations.
Cheng Z; Li X; Ding J
Cancer Lett; 2016 Sep; 379(2):230-8. PubMed ID: 26272183
[TBL] [Abstract][Full Text] [Related]
14. Integrin α6 (CD49f), The Microenvironment and Cancer Stem Cells.
Bigoni-Ordóñez GD; Czarnowski D; Parsons T; Madlambayan GJ; Villa-Diaz LG
Curr Stem Cell Res Ther; 2019; 14(5):428-436. PubMed ID: 30280675
[TBL] [Abstract][Full Text] [Related]
15. Stem cell quiescence.
Li L; Bhatia R
Clin Cancer Res; 2011 Aug; 17(15):4936-41. PubMed ID: 21593194
[TBL] [Abstract][Full Text] [Related]
16. The cancer stem-cell signaling network and resistance to therapy.
Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment.
Tomellini E; Touil Y; Lagadec C; Julien S; Ostyn P; Ziental-Gelus N; Meignan S; Lengrand J; Adriaenssens E; Polakowska R; Le Bourhis X
Stem Cells; 2015 Feb; 33(2):342-53. PubMed ID: 25286822
[TBL] [Abstract][Full Text] [Related]
19. The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.
Fonseca NA; Cruz AF; Moura V; Simões S; Moreira JN
Crit Rev Oncol Hematol; 2017 May; 113():111-121. PubMed ID: 28427501
[TBL] [Abstract][Full Text] [Related]
20. Breast-cancer stem cells-beyond semantics.
Badve S; Nakshatri H
Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
